Asia-Pacific cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.2% during the forecast period. The significant prevalence of cancer and increasing launches of new monoclonal antibodies are some pivotal factors accelerating market growth. As per the World Health Organization (WHO), the number of new cancer incidences in China was nearly 4.3 […]
